Gennisium Pharma is a new European Specialty Pharma Company, dedicated to the development, registration and commercialization of special medicines for Neonatology with global reach.
Our mission is to provide health care practitioners and neonatal intensive care units with novel and suitable formulations of medicines needed to prevent or treat neonatal diseases and conditions.
Our method is to reposition known molecules on neonatal indications, in developing formulations and presentations suitable to this population and seize development opportunities of hybrid drugs.